Form 4 holding
Director
Bicara Therapeutics Inc.
- Security class
- Common Stock
- Shares / value
- 4,443,122
- Estimated value
- $58,842,042
- Report date
- 16 Sep 2024
- Price
- $13.24
- Ownership
- By Biocon Limited
Kiran Mazumdar-Shaw - Director at Bicara Therapeutics Inc.
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- BCAX on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Kiran Mazumdar-Shaw since 07 Sep 2025
Reported holdings for Kiran Mazumdar-Shaw in Bicara Therapeutics Inc.
Form 4 holding
Director
Bicara Therapeutics Inc.
- Security class
- Common Stock
- Shares / value
- 1,080,775
- Estimated value
- $14,313,136
- Report date
- 16 Sep 2024
- Price
- $13.24
- Ownership
- By Biocon Pharma Inc.
Form 4 holding
Director
Bicara Therapeutics Inc.
- Security class
- Common Stock
- Shares / value
- 432,736
- Estimated value
- $5,730,896
- Report date
- 16 Sep 2024
- Price
- $13.24
- Ownership
- By Carica Investments
Form 4 holding
Director
Bicara Therapeutics Inc.
- Security class
- Common Stock
- Shares / value
- 324,552
- Estimated value
- $4,298,172
- Report date
- 16 Sep 2024
- Price
- $13.24
- Ownership
- By Glentech International
Form 4 holding
Director
Bicara Therapeutics Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 19,475
- Estimated value
- Report date
- 09 Jun 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director
Bicara Therapeutics Inc.
- Security class
- Series Seed Redeemable Convertible Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 16 Sep 2024
- Price
- Ownership
- By Biocon Limited
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director
Bicara Therapeutics Inc.
- Security class
- Series Seed Redeemable Convertible Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 16 Sep 2024
- Price
- Ownership
- By Biocon Pharma Inc.
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director
Bicara Therapeutics Inc.
- Security class
- Series Seed Redeemable Convertible Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 16 Sep 2024
- Price
- Ownership
- By Carica Investments
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director
Bicara Therapeutics Inc.
- Security class
- Series Seed Redeemable Convertible Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 16 Sep 2024
- Price
- Ownership
- By Glentech International
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Kiran Mazumdar-Shaw in Bicara Therapeutics Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.